Benzinga's Top Downgrades

By: via Benzinga
Berenberg downgraded Bristol-Myers Squibb Co (NYSE: BMY) from Buy to Hold. The price target for Bristol-Myers Squibb ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.